Alexandria Real Estate Equities, Inc.

Alexandria Real Estate Equities, Inc.

Alexandria Real Estate Equities, Inc.

Overview
Date Founded

1994

Headquarters

385 East Colorado Boulevard,Suite 299,Pasadena, CA 91101

Type of Company

Public

Employees (Worldwide)

439

Industries

Trusts & Funds
Real Estate
Real Estate Investment Trusts

Company Description

Alexandria Real Estate Equities, Inc. is an urban office real estate investment trust, which engages in the ownership, operation, development, and redevelopment of life science and technology properties. It also provides a space for lease to the life science and technology industries which are primarily located in AAA urban innovation cluster locations. The company was founded by Alan D. Gold, Gary A. Kreitzer, Joel S. Marcus, and Jerry M. Sudarsky in October 1994 and is headquartered in Pasadena, CA.

Contact Data
Trying to get in touch with decision makers at Alexandria Real Estate Equities, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Chief Executive Officer & Co-Chief Investment Officer

Co-Chief Executive Officer

Executive Vice President, Real Estate Legal Affairs & Assistant Secretary

Co-President

Co-Chief Operating Officer & Chief Strategic Transactions Officer

Co-Chief Operating Officer

General Counsel & Secretary

Chief Development Officer

Chief Accounting Officer

Co-President, Chief Financial Officer & Principal Accounting Officer

Board of Directors

Managing Partner, Life Science Healthcare Investment Team at SVB Capital

President & Executive Director at Foundation for the National Institutes of Health, Inc.

Partner at Kirkland & Ellis LLP

Co-Founder at O'Brien/Atkins Associates PA

Chief Financial Officer at Industrial Realty Group LLC

Co-Founder at Renaissance Macro Research LLC

Senior Management Consultant at Alexandria Real Estate Equities, Inc.

Partner, New York, Raleigh & Washington at Cain Global Partners LLC

Co-Founder at Alexandria Real Estate Equities, Inc.

Paths to Alexandria Real Estate Equities, Inc.
Potential Connections via
Relationship Science
You
Alexandria Real Estate Equities, Inc.
Owners & Shareholders
Details Hidden

APG US’ portfolio includes Fixed Income, Private Real Estate, and Infrastructure. The Fixed Income Portfolios utilizes bottom-up issue selection combined with top-down duration management and sector allocation in a disciplined, quantifiable, and reproducible manner. The firm invests in a broad spectrum of fixed income sectors that convey different risks, diversification of return and alpha sources are essential elements of the investment process. The Listed Real Estate strategy uses fundamental analysis to form the basis for investment decisions. The Private Real Estate investment strategy uses quantitative analysis, which relies upon objective analysis of market conditions and asset valuation and underwriting, in addition to fundamental research, to form the basis for evaluating investment opportunities. The Infrastructure investment strategy focuses on private infrastructure businesses and assets.

Details Hidden

At Principal Global Investors, designing and delivering the investment solutions that our clients need, when they need them, is our singular and constant focus—and the diverse group of specialized investment boutiques that comprise our asset management business are an important factor in this endeavor. We offer investment strategies that support the growing demand for income and yield, and we leverage our quality-focused alpha and beta offerings in both developed and emerging markets. Our multi-boutique strategy is designed to provide comprehensive investment solutions for our clients. Our growing network of specialized investment boutiques and teams delivers focused areas of expertise in several areas: asset allocation, equities, fixed income, real estate, currency management, stable value, and other structured investment strategies.

Details Hidden

BAMCO’s investment strategy is to invest in growth businesses for capital appreciation potential. Each portfolio manager’s ability to choose appropriate investments for an account has a significant impact on their ability to achieve an account’s investment objective. The firm’s investment professionals are focused on fundamental analyses of businesses. Their primary objective is to understand the key drivers of growth and profitability of each company in which they invest. They analyze the following financial information: income statement, cash flow statement, balance sheet, turnover and ROE metrics, unit economics, and other company-specific data. This information is filtered through their valuation models, which they use to extrapolate long-term trends. They have meetings with the management which is a critical element of the firm’s research process.

Recent Transactions
Details Hidden

Alexandria Real Estate Equities, Inc. issued USD Common Stock

Details Hidden

Alexandria Real Estate Equities, Inc. issued USD Common Stock

Details Hidden

Alexandria Real Estate Equities, Inc. issued USD Common Stock

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Underwriter

Advised onAlexandria Real Estate Equities, Inc. issued USD Common Stock

Underwriter

Advised onAlexandria Real Estate Equities, Inc. issued USD Common Stock

Underwriter

Advised onAlexandria Real Estate Equities, Inc. issued USD Common Stock

Co-Head of Americas Real Estate Investment Banking

Advised onAlexandria Real Estate Equities, Inc. issued USD Common Stock

Legal Advisor

Advised onAlexandria Real Estate Equities, Inc. issued USD Common Stock

Assistant General Counsel

Advised onAlexandria Real Estate Equities, Inc. issued USD Common Stock

Advisors & Consultants
Legal Advisor

Partner at Skadden, Arps, Slate, Meagher & Flom LLP

Real Estate Agent

Senior Vice President/Partner at CBRE Group, Inc.

Legal Advisor

Partner at Skadden, Arps, Slate, Meagher & Flom LLP

Clients

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Uber Technologies, Inc. offers a mobile application enabling users arrange and schedule transportation. The firm uses application to receive ride requests, and then sends out these requests to drivers who transport customers to their final destination. The company was founded by Oscar Salazar, Travis Kalanick and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by John Kennedy Clarke, Paul R. Schimmel and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Key Stats and Financials As of 2019
Market Capitalization
$20.8B
Total Enterprise Value
$26.3B
Earnings Per Share
$3.12
Revenue
$1.53B
Net Profit
$357M
EBITDAMargin
74.37%
EBITDA
$1.14B
Enterprise Value / Sales
17.15x
TEVNet Income
73.68x
Debt TEV
0.27x
Total Debt
$7.05B
Total Equity
$10.2B
Enterprise Value EBITDAOperating
22.82x
Three Year Compounded Annual Growth Rate Of Revenue
18.95%
Non-Profit Donations & Grants
Investments
Details Hidden

Avidity Biosciences, Inc. engages in the research and development of biopharmaceutical products. It develops Nano-Medicine Platform that provides nano-medicines for the treatment of cancer and other diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis and Francis Patrick McCormick on November 13, 2012 and is headquartered in La Jolla, CA.

Details Hidden

Cradle Genomics, Inc. engages in researching and developing life sciences. The company was founded by Randy Armant, Richard Shippy and Sascha Drewlo and is headquartered in San Diego, CA.

Details Hidden

Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Alexandria Real Estate Equities, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Alexandria Real Estate Equities, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Alexandria Real Estate Equities, Inc..